Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating ...

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New ...

Biogen forecast 2026 profit above Wall Street estimates on Friday, banking on demand for newer medicines and its Alzheimer's ...

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system?

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...

Appealing an insurance claim denial with multiple sclerosis often requires following the rules and being persistent.

Chennai: At 25, Bhanupriya was just another TNPSC aspirant from Madurai, preparing for her exams. One day, she lost partial ...

With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in ...